As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – Règlement (UE) 2025/40 du Parlement européen et du Conseil du 19 décembre...

Les produits doivent être correctement emballés afin d’être protégés et faciles à transporter depuis le lieu où ils sont produits jusqu’au lieu où ils...
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) - updated information

Switzerland – Swissmedic assessment of post-market surveillance documentation

Manufacturers need to monitor their medical devices on the market because some trends may become visible only after market launch, when a device is...

Europe- MDCG 2019-6 Rev5 Questions and answers: Requirements relating to notified bodies

Guidance documents are by definition not compulsory. However, all guidance documents endorsed by the MDCG reflect the interpretation of the EU law jointly agreed by the...

Europe – European Commission announces pilot for coordinated assessment of clinical investigations

EU Member States have launched a pilot program to accept single applications for the assessment of clinical investigations and performance studies, coordinated by the...

Europe – EMA establishes regular procedure for scientific advice on certain high-risk medical devices

EMA, in close collaboration with the European Commission, has established a standard procedure for manufacturers of certain high-risk medical devices to request scientific advice on their...
TÜV Rheinland Becomes 5th Notified Body Designated Under MDR

Europe – Règlement D’exécution (UE) 2025/117 de la Commission du 24 janvier 2025

LA COMMISSION EUROPÉENNE, vu le traité sur le fonctionnement de l’Union européenne, vu le règlement (UE) 2021/2282 du Parlement européen et du Conseil du 15 décembre...

Europe – Revised versions and new guidance are available in the EMDN section

MDCG 2025-1 EMDN Ad hoc procedure  January 2025 MDCG 2025-2 Summary of EMDN 2024 Submissions and outcome of annual revision January 2025 MDCG 2025-3 EMDN Version...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – MHRA guidance on new Medical Devices Post-Market Surveillance requirements

A suite of guidance has been published by the Medicines and Healthcare products Regulatory Agency (MHRA). This guidance is designed to help medical device manufacturers...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – Implementation of medical devices future regime

The government intends to introduce new regulations for  medical devices that prioritise patient safety, give patients access to the medical devices they need and...

Europe – MDCG 2024-8 Rev. 1 Preliminary assessment review template – ...

This document has been endorsed by the Medical Device Coordination Group (MDCG) established by Article 103 of Regulation (EU) 2017/745. The MDCG is composed...

NOS PROCHAINES FORMATIONS